Quantbot Technologies’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Quantbot Technologies's LMAT Position: Q2 2026 in Review
Quantbot Technologies reduced its LeMaitre Vascular (LMAT) stake by 53% in Q2 2026, selling an estimated $1.64M and leaving 14,095 shares worth $1.35M. The position accounts for 0.05% of the portfolio, ranked #504.
Quantbot Technologies first reported a position in LMAT in Q2 2019 and has held it in 20 quarters since. The position peaked at $3.28M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Quantbot Technologies held 14,095 shares of LeMaitre Vascular worth $1.35M as of Q2 2026.
- Quantbot Technologies sold 15,971 LeMaitre Vascular shares in Q2 2026, an estimated $1.64M.
- LeMaitre Vascular made up 0.05% of Quantbot Technologies's portfolio in Q2 2026, its #504 holding.
- Quantbot Technologies first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 20 quarters since.
- Quantbot Technologies's LeMaitre Vascular position peaked at $3.28M in Q1 2026.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.